亚太地区数字基因组市场预测至 2027 年 - COVID-19 影响和区域分析(按产品)(DNA/RNA 分析、测序芯片、测序和分析仪器、样品制备仪器、测序和分析软件);应用(诊断、农业、学术研究、药物发现、个性化医疗、其他应用);最终用户(诊断和法医实验室、学术研究机构、医院、其他最终用户)和国家/地区

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027


No. of Pages: 142    |    Report Code: TIPRE00012173    |    Category: Life Sciences

Asia Pacific Digital Genome Market

市场介绍

数字基因组是细胞或生物体中遗传物质的完整先进数字排列。这是一种积累慢性病信息的更简单的方法,专家可以利用它来更好地了解遗传性疾病。数字基因组学涉及基因和基因。他们的作用和目标是识别和解决慢性疾病背后的因素以解决这些问题。这项技术引发了以发明为中心的研究和应用领域的反抗。系统生物学,以加快洞察最复杂的遗传系统。

市场概况和动态

亚太地区数字基因组市场将从 2019 年的 20.7727 亿美元增至 2027 年的 41.1886 亿美元。预计 2019-2027 年该市场将以 9.1% 的复合年增长率增长。慢性病患病率增加和资金增加等因素基因组学预计将推动数字基因组市场的增长。然而,市场可能会受到预测期内缺乏熟练专业人员等风险因素的影响。

关键细分市场

从产品来看,2019年测序和分析仪器领域占据亚太数字基因组市场最大份额。诊断和法医实验室领域占据亚太数字基因组市场最大份额2019 年,按最终用户划分。就应用而言,诊断细分市场在 2019 年亚太数字基因组市场中占据最大份额。

主要来源和公司列出

与亚太数字基因组市场报告相关的几个主要一手和二手来源是世界卫生组织 (WHO)、国家卫生健康委员会 (NHC)、Globocan 2019 报告等.

购买报告的理由

  • 它提供了对亚太地区的了解、数字基因组市场格局,并确定最有可能保证强劲回报的数字基因组市场细分。
  • 它通过了解数字基因组不断变化的竞争格局来指导保持领先地位。亚太数字基因组市场。
  • 通过识别最有可能销售前景的细分市场,帮助有效规划数字基因组市场的并购和合作伙伴关系
  • 它通过对亚太数字基因组市场各个细分市场的数字基因组市场表现进行敏锐和全面的分析,促进明智的业务决策。
  • 它提供数字基因组市场2019年至2027年期间基于各个细分市场的市场收入预测。

亚太数字基因市场细分

按产品

  • 测序和分析仪器
  • DNA/RNA 分析
  • 测序和分析软件
  • 测序芯片
  • 样品制备仪器

按应用

  • 诊断
  • 药物发现
  • 学术研究
  • 个性化医疗
  • 农业
  • 其他

按最终用户

  • 诊断和法医实验室
  • 学术研究机构< /span>
  • 医院
  • 其他

按国家/地区

  • 中国
  • 日本
  • 印度
  • 韩国
  • 澳大利亚

公司简介

  • Thermo FISHER SCIENTIFIC INC
  • Illumina, Inc
  • F.霍夫曼拉罗氏有限公司
  • QIAGEN
  • bioMerieux SA


Asia Pacific Digital Genome Strategic Insights

Strategic insights for Asia Pacific Digital Genome involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-digital-genome-market-strategic-framework.webp
Get more information on this report

Asia Pacific Digital Genome Report Scope

Report Attribute Details
Market size in 2019 US$ 2,077.27 Million
Market Size by 2027 US$ 4,118.86 Million
Global CAGR (2019 - 2027) 9.1%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By 产品
  • DNA/RNA分析
  • 测序芯片
  • 测序和分析仪
  • 样品制备仪器
  • 测序和分析软件
By 应用
  • 诊断
  • 农业
  • 学术研究
  • 药物研发
  • 个性化医疗
  • 其他应用
By 最终用户
  • 诊断和法医实验室
  • 学术研究机构
  • 医院
  • 其他最终用户
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • THERMO FISHER SCIENTIFIC INC
  • Illumina, Inc
  • F. HOFFMANN-LA ROCHE LTD
  • QIAGEN
  • bioMerieux SA
  • Get more information on this report

    Asia Pacific Digital Genome Regional Insights

    The regional scope of Asia Pacific Digital Genome refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-digital-genome-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Digital Genome Market

    The List of Companies - Asia Pacific Digital Genome Market

    1. THERMO FISHER SCIENTIFIC INC
    2. Illumina, Inc
    3. F. HOFFMANN-LA ROCHE LTD
    4. QIAGEN
    5. bioMerieux SA

     

    Frequently Asked Questions
    How big is the Asia Pacific Digital Genome Market?

    The Asia Pacific Digital Genome Market is valued at US$ 2,077.27 Million in 2019, it is projected to reach US$ 4,118.86 Million by 2027.

    What is the CAGR for Asia Pacific Digital Genome Market by (2019 - 2027)?

    As per our report Asia Pacific Digital Genome Market, the market size is valued at US$ 2,077.27 Million in 2019, projecting it to reach US$ 4,118.86 Million by 2027. This translates to a CAGR of approximately 9.1% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Digital Genome Market report typically cover these key segments-

  • 产品 (DNA/RNA分析, 测序芯片, 测序和分析仪, 样品制备仪器, 测序和分析软件)
  • 应用 (诊断, 农业, 学术研究, 药物研发, 个性化医疗, 其他应用)
  • 最终用户 (诊断和法医实验室, 学术研究机构, 医院, 其他最终用户)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Digital Genome Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Digital Genome Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
  • Who are the major players in Asia Pacific Digital Genome Market?

    The Asia Pacific Digital Genome Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • THERMO FISHER SCIENTIFIC INC
  • Illumina, Inc
  • F. HOFFMANN-LA ROCHE LTD
  • QIAGEN
  • bioMerieux SA
  • Who should buy this report?

    The Asia Pacific Digital Genome Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Digital Genome Market value chain can benefit from the information contained in a comprehensive market report.